|
| 37945451 | The Efficacy and Safety of Metastasis-directed Therapy in Patients with Prostate Cancer: A Systematic Review and Meta-analysis of Prospective Studies. | Eur Urol | 2024 |
| 37487813 | Stereotactic Magnetic Resonance-guided Adaptive Radiation Therapy for Localized Kidney Cancer: Early Outcomes from a Prospective Phase 1 Trial and Supplemental Cohort. | Eur Urol Oncol | 2024 |
| 37517600 | Assessing the Feasibility of Using Artificial Intelligence-Segmented Dominant Intraprostatic Lesion for Focal Intraprostatic Boost With External Beam Radiation Therapy. | Int J Radiat Oncol Biol Phys | 2024 |
| 35306541 | Localized prostate cancer disparities in risk group at presentation and access to treatment for Hispanic men. | Prostate Cancer Prostatic Dis | 2023 |
| 37665729 | Observer preference of artificial intelligence-generated versus clinical prostate contours for ultrasound-based high dose rate brachytherapy. | Med Phys | 2023 |
| 37485697 | Acute toxicity comparison of magnetic resonance-guided adaptive versus fiducial or computed tomography-guided non-adaptive prostate stereotactic body radiotherapy: AÂ systematic review and meta-analysis. | Cancer | 2023 |
| 37120487 | ASO Author Reflections: Colon Cancer Disparities in Stage at Presentation and Time to Surgery for Asian Americans, Native Hawaiians, and Pacific Islanders. | Ann Surg Oncol | 2023 |
| 37017832 | Colon Cancer Disparities in Stage at Presentation and Time to Surgery for Asian Americans, Native Hawaiians, and Pacific Islanders: A Study with Disaggregated Ethnic Groups. | Ann Surg Oncol | 2023 |
| 37207301 | Genetic and Genomic Testing for Prostate Cancer: Beyond DNA Repair. | Am Soc Clin Oncol Educ Book | 2023 |
| 37402623 | Leveraging national and global political determinants of health to promote equity in cancer care. | J Natl Cancer Inst | 2023 |
| 37003878 | Determinants of widespread metastases and of metastatic tropism in patients with prostate cancer: A genomic analysis of primary and metastatic tumors. | Urol Oncol | 2023 |
| 37003085 | Management of patients with advanced prostate cancer-metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022. | Eur J Cancer | 2023 |
| 37267579 | Early Treatment Intensification in Metastatic Hormone-Sensitive Prostate Cancer. | J Clin Oncol | 2023 |
| 37262399 | Disparities in Diagnosis, Treatment Access, and Time to Treatment Among Hispanic Men With Metastatic Prostate Cancer. | JCO Oncol Pract | 2023 |
| 36522269 | Distinct Profiles of DNA Repair Activity Define Favorable-risk Prostate Cancer Subtypes With Divergent Outcome. | Clin Genitourin Cancer | 2023 |
| 36399692 | Shorter Radiation Regimens and Treatment Noncompletion Among Patients With Breast and Prostate Cancer in the United States: An Analysis of Racial Disparities in Access and Quality. | JCO Oncol Pract | 2023 |
| 36875903 | Uncontrolled Cardiovascular Risk Factors in Prostate Cancer Patients: Are We Leaving Too Much on the Table? | JACC CardioOncol | 2023 |
| 36870853 | Transcriptomic Heterogeneity in High-risk Prostate Cancer and Implications for Extraprostatic Disease at Presentation on Prostate-specific Membrane Antigen Positron Emission Tomography. | Eur Urol Oncol | 2023 |
| 36763576 | Gaining metabolic insight in older men undergoing androgen deprivation therapy for prostate cancer (the ADT & Metabolism Study): Protocol of a longitudinal, observational, cohort study. | PLoS One | 2023 |
| 36494221 | Management of Patients with Advanced Prostate Cancer. Part I: Intermediate-/High-risk and Locally Advanced Disease, Biochemical Relapse, and Side Effects of Hormonal Treatment: Report of the Advanced Prostate Cancer Consensus Conference 2022. | Eur Urol | 2023 |
| 36596347 | Analysis of a Biopsy-Based Genomic Classifier in High-Risk Prostate Cancer: Meta-Analysis of the NRG Oncology/Radiation Therapy Oncology Group 9202, 9413, and 9902 Phase 3 Randomized Trials. | Int J Radiat Oncol Biol Phys | 2023 |
| 34711459 | Radiation Dose to the Intraprostatic Urethra Correlates Strongly With Urinary Toxicity After Prostate Stereotactic Body Radiation Therapy: A Combined Analysis of 23 Prospective Clinical Trials. | Int J Radiat Oncol Biol Phys | 2022 |
| 35847547 | Magnetic Resonance-Guided Prostate Stereotactic Body Radiation Therapy With Daily Online Plan Adaptation: Results of a Prospective Phase 1 Trial and Supplemental Cohort. | Adv Radiat Oncol | 2022 |
| 35652585 | Second malignancy probabilities in patients with prostate cancer treated with whole pelvis radiation therapy versus prostate only radiation therapy. | Prostate | 2022 |
| 35675855 | The Influence of the Pretreatment Immune State on Response to Radiation Therapy in High-Risk Prostate Cancer: A Validation Study From NRG/RTOG 0521. | Int J Radiat Oncol Biol Phys | 2022 |
| 35654645 | Corrigendum to definitive and sustained increase in prostate cancer metastases in the United States. | Urol Oncol | 2022 |
| 35947686 | The Increasing Importance of Rigorous Real-World Evidence. | JNCI Cancer Spectr | 2022 |
| 36187555 | Genomic alterations predictive of poor clinical outcomes in pan-cancer. | Oncotarget | 2022 |
| 35877007 | Shared burden: the association between cancer diagnosis, financial toxicity, and healthcare cost-related coping mechanisms by family members of non-elderly patients in the USA. | Support Care Cancer | 2022 |
| 35190652 | Racial disparities in treatment delay among younger men with prostate cancer. | Prostate Cancer Prostatic Dis | 2022 |
| 34709962 | Prostate Cancer Disparities in Risk Group at Presentation and Access to Treatment for Asian Americans, Native Hawaiians, and Pacific Islanders: A Study With Disaggregated Ethnic Groups. | JCO Oncol Pract | 2022 |
| 34530092 | Boosting the Abscopal Effect Using Immunogenic Biomaterials With Varying Radiation Therapy Field Sizes. | Int J Radiat Oncol Biol Phys | 2022 |
| 34561128 | Exercise: A Treatment That Should Be Prescribed With Radiation Therapy. | Int J Radiat Oncol Biol Phys | 2022 |
| 29254671 | Optimizing androgen deprivation therapy with radiation therapy for aggressive localized and locally advanced prostate cancer. | Urol Oncol | 2021 |
| 33570548 | Validation of a 22-Gene Genomic Classifier in Patients With Recurrent Prostate Cancer: An Ancillary Study of the NRG/RTOG 9601 Randomized Clinical Trial. | JAMA Oncol | 2021 |
| 33905530 | Risk of cardiovascular mortality with androgen deprivation therapy in prostate cancer: A secondary analysis of the Prostate, Lung, Colorectal, and Ovarian (PLCO) Randomized Controlled Trial. | Cancer | 2021 |
| 33840559 | Prostate-specific Membrane Antigen and Fluciclovine Transporter Genes are Associated with Variable Clinical Features and Molecular Subtypes of Primary Prostate Cancer. | Eur Urol | 2021 |
| 33779742 | Assessment of Simulated SARS-CoV-2 Infection and Mortality Risk Associated With Radiation Therapy Among Patients in 8 Randomized Clinical Trials. | JAMA Netw Open | 2021 |
| 33750906 | Correlative analysis between two commercially available post-prostatectomy genomic tests. | Prostate Cancer Prostatic Dis | 2021 |
| 33725174 | Financial worry and psychological distress among cancer survivors in the United States, 2013-2018. | Support Care Cancer | 2021 |
| 33662287 | Intermediate clinical endpoints for surrogacy in localised prostate cancer: an aggregate meta-analysis. | Lancet Oncol | 2021 |
| 33723523 | The Case for Brachytherapy: Why It Deserves a Renaissance. | Adv Radiat Oncol | 2021 |
| 33857569 | Clinical characterization of radiation-associated muscle-invasive bladder cancer. | Urology | 2021 |
| 33497248 | Initial Management of Noncastrate Advanced, Recurrent, or Metastatic Prostate Cancer: ASCO Guideline Update. | J Clin Oncol | 2021 |
| 33630666 | Disparities in Refusal of Locoregional Treatment for Prostate Adenocarcinoma. | JCO Oncol Pract | 2021 |
| 35071831 | Evaluating the Role of Stereotactic Body Radiation Therapy With Respect to Androgen Receptor Signaling Inhibitors for Oligometastatic Prostate Cancer. | Adv Radiat Oncol | 2021 |
| 34964855 | Comparison of Response to Definitive Radiotherapy for Localized Prostate Cancer in Black and White Men: A Meta-analysis. | JAMA Netw Open | 2021 |
| 34551377 | Novel genomic signature predictive of response to immune checkpoint blockade: A pan-cancer analysis from project Genomics Evidence Neo-plasia Information Exchange (GENIE). | Cancer Genet | 2021 |
| 33934574 | Association of Medicaid expansion and insurance status, cancer stage, treatment and mortality among patients with cervical cancer. | Cancer Rep (Hoboken) | 2021 |
| 34171451 | Second malignancy probabilities in prostate cancer patients treated with SBRT and other contemporary radiation techniques. | Radiother Oncol | 2021 |